Literature DB >> 8058726

Transcriptional activation by TAL1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities.

I Sánchez-García1, T H Rabbitts.   

Abstract

Proteins that appear to participate in transcriptional control of gene expression are increasingly implicated in leukemias and malignant solid tumors. We report here that the N-terminal domains of the proteins TAL1 (ectopically activated in T-cell acute leukemias after chromosomal abnormalities caused by V-D-J recombinase error) (V, variable; D, diversity; J, joining) and FUS-CHOP (a liposarcoma tumor-specific fusion protein that is produced as a result of a chromosomal translocation) can function as transcription activators of specific responsive reporter genes. The result with TAL1 provides evidence that transcriptional activation can be mediated by a gene activated by translocation in T-cell acute leukemias. In the case of the liposarcoma, transactivation by the FUS-CHOP protein occurs because the FUS transcriptional activation domain is added to the DNA-binding CHOP protein normally lacking such activity. Therefore, the association of transcriptional activation and DNA-binding elements is a common consequence in proteins activated or newly created as fusion proteins after chromosomal translocations in acute leukemias and in malignant solid tumors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058726      PMCID: PMC44505          DOI: 10.1073/pnas.91.17.7869

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins.

Authors:  H L Hsu; J T Cheng; Q Chen; R Baer
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

2.  The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13.

Authors:  T Boehm; L Foroni; Y Kaneko; M F Perutz; T H Rabbitts
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

3.  Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia.

Authors:  M Hatano; C W Roberts; M Minden; W M Crist; S J Korsmeyer
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

Review 4.  Oncogenic conversion of transcription factors by chromosomal translocations.

Authors:  M L Cleary
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

Review 5.  Activators and targets.

Authors:  M Ptashne; A A Gann
Journal:  Nature       Date:  1990-07-26       Impact factor: 49.962

6.  TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11).

Authors:  B Royer-Pokora; U Loos; W D Ludwig
Journal:  Oncogene       Date:  1991-10       Impact factor: 9.867

Review 7.  LIM domain proteins in leukaemia and development.

Authors:  I Sánchez-García; T H Rabbitts
Journal:  Semin Cancer Biol       Date:  1993-12       Impact factor: 15.707

8.  Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor.

Authors:  J Nourse; J D Mellentin; N Galili; J Wilkinson; E Stanbridge; S D Smith; M L Cleary
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

9.  Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia.

Authors:  L Brown; J T Cheng; Q Chen; M J Siciliano; W Crist; G Buchanan; R Baer
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

10.  The tcl-3 proto-oncogene altered by chromosomal translocation in T-cell leukemia codes for a homeobox protein.

Authors:  M Lu; Z Y Gong; W F Shen; A D Ho
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

View more
  19 in total

1.  Induction of a secreted protein by the myxoid liposarcoma oncogene.

Authors:  M Kuroda; X Wang; J Sok; Y Yin; P Chung; J W Giannotti; K A Jacobs; L J Fitz; P Murtha-Riel; K J Turner; D Ron
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.

Authors:  P D Aplan; C A Jones; D S Chervinsky; X Zhao; M Ellsworth; C Wu; E A McGuire; K W Gross
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

3.  Self-assembled FUS binds active chromatin and regulates gene transcription.

Authors:  Liuqing Yang; Jozsef Gal; Jing Chen; Haining Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-01       Impact factor: 11.205

Review 4.  Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics.

Authors:  V H Le; M Inai; R M Williams; T Kan
Journal:  Nat Prod Rep       Date:  2015-02       Impact factor: 13.423

5.  Retroviral vector design for gene therapy of cancer: specific inhibition and tagging of BCR-ABLp190 cells.

Authors:  B García-Hernández; I Sánchez-García
Journal:  Mol Med       Date:  1996-01       Impact factor: 6.354

6.  hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II.

Authors:  A Bertolotti; Y Lutz; D J Heard; P Chambon; L Tora
Journal:  EMBO J       Date:  1996-09-16       Impact factor: 11.598

7.  The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells.

Authors:  Katarina Engström; Helena Willén; Christina Kåbjörn-Gustafsson; Carola Andersson; Marita Olsson; Melker Göransson; Sofia Järnum; Anita Olofsson; Elisabeth Warnhammar; Pierre Aman
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

8.  Nuclear expression of FLT1 and its ligand PGF in FUS-DDIT3 carrying myxoid liposarcomas suggests the existence of an intracrine signaling loop.

Authors:  Mattias K Andersson; Melker Göransson; Anita Olofsson; Carola Andersson; Pierre Aman
Journal:  BMC Cancer       Date:  2010-06-01       Impact factor: 4.430

9.  Ebp1 sumoylation, regulated by TLS/FUS E3 ligase, is required for its anti-proliferative activity.

Authors:  S-M Oh; Z Liu; M Okada; S-W Jang; X Liu; C-B Chan; H Luo; K Ye
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

10.  DDIT3/CHOP and the sarcoma fusion oncoprotein FUS-DDIT3/TLS-CHOP bind cyclin-dependent kinase 2.

Authors:  Christoffer Bento; Mattias K Andersson; Pierre Aman
Journal:  BMC Cell Biol       Date:  2009-12-17       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.